Results
1 -
3 of
3Development of Subtype-Selective GABAA Receptor Compounds for the Treatment of Anxiety, Sleep Disorders and Epilepsy, GABA and Sleep A phase II/III clinical trial investigating the treatment of insomnia with a bilayer tablet formulation of adipiplon has been suspended, Reactions Weekly